COIOSDeep risk insights through multi-disciplinary research across the globe
A narrow city street with a church steeple in the background
Item refines Peer-reviewed Added

Heart-type fatty acid-binding protein detects coronary disease poorly but tracks deaths

Heart-type fatty acid-binding protein detected coronary disease poorly in 2,690 patients, but eight-year mortality rose from 7.7% in the lowest quartile of the marker to 44% in the highest.

Heart-type fatty acid-binding protein was measured at rest and under stress in 2,690 patients assessed for coronary disease that restricts blood flow, present in 34%. The marker separated those with the disease from those without only slightly better than chance, with an area under the curve of 0.561. Over eight years, all-cause mortality rose from 7.7% in the lowest quartile of the marker to 44% in the highest.

Why it is interesting: A marker proposed for detecting coronary disease identified who later died rather than who had it.

Source
Clinica Chimica Acta, 17 September 2026
Paper
Diagnostic and prognostic performance of heart-type fatty acid-binding protein in functionally relevant coronary artery disease
Authors
Tsianakas E, Kul S, Nafaa F, Durak K, Lopez-Ayala P, Kaplan E et al.
DOI
10.1016/j.cca.2026.121346
Type
Peer-reviewed article
Design
Prospective diagnostic cohort with central adjudication by perfusion imaging and angiography, n=2690 diagnostic and n=2645 prognostic, 8-year follow-up
Verdict
Refines prior evidence
Driver
Heart and stroke
Free full text
Free to read at the publisher
Abstract — the authors' own words, CC BY

Background

This study aimed to evaluate the diagnostic and prognostic utility of heart-type fatty acid-binding protein (H-FABP) in patients with suspected functionally relevant coronary artery disease (fCAD). Methods

The presence of fCAD was centrally adjudicated using myocardial perfusion imaging and coronary angiography. H-FABP high-sensitivity cardiac troponin T (hs-cTnT), and high-sensitivity cardiac troponin I (hs-cTnI) concentrations were measured at rest, peak stress, and 2 h after stress in a blinded fashion.Centrally adjudicated outcomes included all-cause death and cardiovascular death during 8-years. Results

Among 2690 patients included in the diagnostic analysis (median age 68 years, 32% women), fCAD was present in 924 individuals (34%). Baseline H-FABP concentrations were higher in patients with fCAD than in those without (29 [23-38] vs 27 [22-35] ng/mL, p Conclusions

H-FABP demonstrated limited diagnostic accuracy for detecting fCAD but is strongly and independently associated with long-term mortality.

Other drivers in Health today